CareLit · DOI-Nachweis · Pneumologie
Pooled analysis of data from the TOMORROW and INPULSIS® trials of nintedanib in IPF
DOI 10.1055/s-0036-1571996
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Neurohr, L Richeldi, V Cottin, M Selman, T Kimura, S Stowasser, KK Brown
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: The 52-week, Phase II TOMORROW trial and two replicate 52-week, Phase III INPULSIS® trials investigated the efficacy and safety of nintedanib 150 mg twice daily (bid) versus placebo in patients with idiopathic pulmonary fibrosis (IPF). Aim: A pooled analysis of data from the TOMORROW and INPULSIS® trials was conducted to obtain a more precise estimate of the treatment effect of nintedanib. Methods: Resul…
Zitieren
Zitierempfehlung
C Neurohr, L Richeldi, V Cottin, M Selman, T Kimura, S Stowasser, KK Brown (2016) Pooled analysis of data from the TOMORROW and INPULSIS® trials of nintedanib in IPF. Pneumologie (02). https://doi.org/10.1055/s-0036-1571996
Mit CareLit weiterarbeiten